Efficacy and short-term safety of intravenous omadacycline as second-line therapy for macrolide- unresponsive Mycoplasma pneumoniae pneumonia in children: a retrospective cohort study
ObjectiveTo evaluate the efficacy and short-term safety of omadacycline as second-line therapy for macrolide-unresponsive Mycoplasma pneumoniae pneumonia (MUMPP) in children aged 8–16 years.MethodsA total of 64 hospitalized children with MUMPP admitted between September 2023 and December 2024 were e...
Gardado en:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2026-07-01
|
| Series: | Frontiers in Cellular and Infection Microbiology |
| Assuntos: | |
| Acceso en liña: | https://www.frontiersin.org/articles/10.3389/fcimb.2026.1863784/full |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|